BioCentury | Aug 11, 2015
Financial News

Turing raises $90M, buys U.S. rights to Daraprim

...marketed generic versions of the drug. Impax acquired the drug in March when it bought Tower Holdings Inc....
Items per page:
1 - 1 of 1
BioCentury | Aug 11, 2015
Financial News

Turing raises $90M, buys U.S. rights to Daraprim

...marketed generic versions of the drug. Impax acquired the drug in March when it bought Tower Holdings Inc....
Items per page:
1 - 1 of 1